A Phase I, Open-Label, Randomized, Crossover Trial in 16 Healthy Subjects to Investigate the Potential Pharmacokinetic Interaction Between Telaprevir and Escitalopram at Steady-State.

Trial Profile

A Phase I, Open-Label, Randomized, Crossover Trial in 16 Healthy Subjects to Investigate the Potential Pharmacokinetic Interaction Between Telaprevir and Escitalopram at Steady-State.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2009

At a glance

  • Drugs Escitalopram; Telaprevir
  • Indications Anxiety disorders; Depressive disorders; Hepatitis C
  • Focus Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 11 Dec 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Planned end date changed from 1 Dec 2009 to 1 Nov 2009 as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top